April19 April 19 is not far away, all will be revealed in due time. Albert Labs Accelerated access to safe and effective psychedelic-assisted therapy. ATAI Life Sciences Pioneering the development of more effective and potentially disease-modifying mental health treatments. Bexson Biomedical Developing a unique formulation of ketamine for chronic and acute pain disorders. Cybin A mushroom life sciences company focused on psychedelic medicines and nutraceutical products. Diamond Therapeutics Developing safe therapies for neuropsychiatric conditions that have the potential to deliver greater impact than current first-line treatments. Gilgamesh The next generation of central nervous system drugs inspired by psychedelic medicines. Hive A global network of next generation mental health centers using psychedelic assisted therapy. MagicMed Industries Supporting and enabling the commercialization of psychedelic-derived pharmaceuticals for brain and mental health. Microdose A media company bringing together everything you need to know about psychedelics. Numinus A biotech company dedicated to providing access to therapies that enhance and supplement existing options. The Third Wave Well-researched, high-quality information specific to the classic psychedelics. Wesana Health Grounded in the science of today, we’re on a mission to treat traumatic brain injury and other mental health ailments using psilocybin and other natural therapies.
